Compagnie Lombard Odier SCmA’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Hold |
0
| – | – | – | 703 |
|
|
2021
Q3 | – | Sell |
-12,500
| Closed | -$437K | – | 677 |
|
|
2021
Q2 | $437K | Buy |
12,500
+10,500
| +525% | +$367K | 0.01% | 245 |
|
|
2021
Q1 | $67K | Buy |
+2,000
| New | +$67K | ﹤0.01% | 478 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 606 |
|
|
2019
Q3 | – | Sell |
-10,000
| Closed | -$61K | – | 542 |
|
|
2019
Q2 | $61K | Hold |
10,000
| – | – | ﹤0.01% | 344 |
|
|
2019
Q1 | $72K | Hold |
10,000
| – | – | ﹤0.01% | 372 |
|
|
2018
Q4 | $74K | Sell |
10,000
-115,000
| -92% | -$851K | ﹤0.01% | 348 |
|
|
2018
Q3 | $676K | Sell |
125,000
-30,000
| -19% | -$162K | 0.02% | 175 |
|
|
2018
Q2 | $552K | Sell |
155,000
-25,000
| -14% | -$89K | 0.02% | 199 |
|
|
2018
Q1 | $366K | Sell |
180,000
-120,000
| -40% | -$244K | 0.01% | 242 |
|
|
2017
Q4 | $790K | Buy |
300,000
+150,000
| +100% | +$395K | 0.01% | 250 |
|
|
2017
Q3 | $786K | Buy |
150,000
+3,000
| +2% | +$15.7K | 0.03% | 223 |
|
|
2017
Q2 | $524K | Sell |
147,000
-22,200
| -13% | -$79.1K | 0.02% | 263 |
|
|
2017
Q1 | $875K | Sell |
169,200
-3,000
| -2% | -$15.5K | 0.03% | 230 |
|
|
2016
Q4 | $654K | Buy |
172,200
+37,200
| +28% | +$141K | 0.02% | 293 |
|
|
2016
Q3 | $1.21M | Buy |
135,000
+3,000
| +2% | +$26.9K | 0.04% | 243 |
|
|
2016
Q2 | $927K | Buy |
132,000
+48,400
| +58% | +$340K | 0.03% | 273 |
|
|
2016
Q1 | $713K | Buy |
83,600
+35,600
| +74% | +$304K | 0.02% | 300 |
|
|
2015
Q4 | $630K | Sell |
48,000
-76,500
| -61% | -$1M | 0.02% | 289 |
|
|
2015
Q3 | $456K | Buy |
124,500
+33,000
| +36% | +$121K | 0.02% | 287 |
|
|
2015
Q2 | $528K | Buy |
91,500
+3,500
| +4% | +$20.2K | 0.02% | 300 |
|
|
2015
Q1 | $514K | Sell |
88,000
-4,000
| -4% | -$23.4K | 0.02% | 306 |
|
|
2014
Q4 | $721K | Sell |
92,000
-52,341
| -36% | -$410K | 0.03% | 227 |
|
|
2014
Q3 | $709K | Buy |
144,341
+42,841
| +42% | +$210K | 0.03% | 245 |
|
|
2014
Q2 | $627K | Buy |
101,500
+9,000
| +10% | +$55.6K | 0.02% | 278 |
|
|
2014
Q1 | $495K | Buy |
+92,500
| New | +$495K | 0.02% | 325 |
|